loading

Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten

pulisher
11:06 AM

What analysts say about NewAmsterdam Pharma Company N.V. Equity Warrant stockHigh-impact investment strategies - Autocar Professional

11:06 AM
pulisher
03:58 AM

Arizona State Retirement System Buys New Shares in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - Defense World

03:58 AM
pulisher
Jul 22, 2025

What analysts say about NewAmsterdam Pharma Company N.V. stockFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. stock priceRapid wealth creation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What makes NewAmsterdam Pharma Company N.V. stock price move sharplyDaily Breakout Picks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma Company N.V. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Major Alzheimer's Discovery: Cardiovascular Drug Shows Promising Brain Health Benefits in 1,727 Patients - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. Equity Warrant stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs during market volatilityFree High-Profit Stock Picks - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Is NewAmsterdam Pharma Company N.V. Equity Warrant a good long term investmentExceptional return forecasts - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is NewAmsterdam Pharma Company N.V. a good long term investmentExplosive portfolio gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

why newamsterdam pharma company n.v. equity warrant stock attracts strong analyst attentionFree Risk Assessment Services - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

When is the best time to buy NewAmsterdam Pharma Company N.V. stockFree Access to Investment Community - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated at The Goldman Sachs Group - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

How NewAmsterdam Pharma Company N.V. stock reacts to Fed policy changesFree Capital Allocation Plans - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Goldman Sachs Initiates Coverage on NewAmsterdam Pharma With Neutral Rating, $27 Price Target - MarketScreener

Jul 17, 2025
pulisher
Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives $42.89 Consensus Price Target from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Jefferies Remains Bullish on NewAmsterdam Pharma (NAMS) - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 16, 2025
pulisher
Jul 16, 2025

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts strong analyst attentionWatchlist Winner Update - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why NewAmsterdam Pharma Company N.V. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How NewAmsterdam Pharma Company N.V. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes NewAmsterdam Pharma Company N.V. Equity Warrant stock price move sharplyAlpha Stock Ideas - Newser

Jul 15, 2025
$22.84
price up icon 4.79%
$36.02
price down icon 0.12%
$102.58
price down icon 0.21%
$27.91
price up icon 5.14%
$113.56
price up icon 1.86%
biotechnology ONC
$295.56
price down icon 0.03%
Kapitalisierung:     |  Volumen (24h):